NCT06491225View on ClinicalTrials.gov

Autologous Tumor-Infiltrating Lymphocyte (GTE-001 Injection ) for Treatment of Patients with Advanced Lung Adenocarcinoma

PHASE1RecruitingINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

July 18, 2024

Primary Completion Date

July 18, 2027

Study Completion Date

July 18, 2027

Conditions

Advanced Lung Adenocarcinoma；Adult

Interventions

BIOLOGICAL

GTE001 injection

GTE-001 injection to treat Advanced lung adenocarcinoma

Trial Locations (1)

102200

RECRUITING

Beijing GoBroad Hospital, Beijing

Sponsors

Lead Sponsor

Grit Biotechnology

All Listed Sponsors

lead

Grit Biotechnology

INDUSTRY